Correlation Between Relay Therapeutics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Relay Therapeutics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Zentalis Pharmaceuticals.
Diversification Opportunities for Relay Therapeutics and Zentalis Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Relay and Zentalis is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Zentalis Pharmaceuticals. In addition to that, Relay Therapeutics is 1.3 times more volatile than Zentalis Pharmaceuticals Llc. It trades about -0.04 of its total potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about 0.06 per unit of volatility. If you would invest 323.00 in Zentalis Pharmaceuticals Llc on September 3, 2024 and sell it today you would earn a total of 38.00 from holding Zentalis Pharmaceuticals Llc or generate 11.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Relay Therapeutics |
| Zentalis Pharmaceuticals |
Relay Therapeutics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Zentalis Pharmaceuticals
The main advantage of trading using opposite Relay Therapeutics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |